XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (5,845,635) $ (4,773,907)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock compensation 2,291,734 2,008,801
Amortization 15,385 10,666
Non-cash lease expense 496
Gain on sale of short-term investments (99,331) (92,915)
Return (loss) on investment in Joint Venture 864 (4,651)
Changes in operating assets and liabilities:    
Accounts receivable 2,111 (5,262)
Accounts receivable - related party 3,007 (540)
Prepaid expenses and other current assets (2,954) 175,245
Inventory 14,353 (1,955)
Accounts payable - related party 2,911
Accounts payable (91,367) 7,008
Accrued expenses (66,714) (128,437)
Accrued expenses - related party (34,000)
Lease liability (4,463)
Net cash used in operating activities (3,809,636) (2,809,914)
Cash flows from investing activities:    
Sale of short-term investments 31,247,000 22,348,611
Purchase of short-term investments (32,004,951) (24,399,610)
Purchase of patents (46,333) (101,936)
Purchase of trademarks (16,887) (52,144)
Net cash used in investing activities (821,171) (2,205,079)
Cash flows from financing activities:    
Sale of common stock for cash, net of financing fees 4,646,397 4,516,184
Net cash provided by financing activities 4,646,397 4,516,184
Net increase (decrease) in cash and cash equivalents 15,590 (498,809)
Cash and cash equivalents - beginning of period 574,485 580,230
Cash and cash equivalents - end of period 590,075 81,421
Non-cash investing and financing activities:    
Unrealized gain (loss) on short-term investments $ (119) $ 80